GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **676 - 700** of **4050** in total

« First

‹ Prev

…

24

25

26

27

28

29

30

31

32

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▼	Arbitrary Fluorescence Units (AFU)
IgG	Patient 2	3	mild	G82348BZ	37
IgM	Patient 2	24	mild	G82348BZ	143
IgM	Patient 2	3	mild	G82348BZ	164
IgA	Patient 3	-180	mild	G82348BZ	249
IgA	Patient 3	11	mild	G82348BZ	370
IgG	Patient 3	-180	mild	G82348BZ	42
IgM	Patient 3	-180	mild	G82348BZ	70
IgA	Patient 3	4	mild	G82348BZ	411
IgG	Patient 3	11	mild	G82348BZ	38
IgG	Patient 3	4	mild	G82348BZ	42
IgM	Patient 3	11	mild	G82348BZ	89
IgM	Patient 3	4	mild	G82348BZ	106
IgA	Patient 4	12	mild	G82348BZ	509
IgG	Patient 4	12	mild	G82348BZ	93
IgM	Patient 4	12	mild	G82348BZ	427
IgA	Patient 1	10	moderate	G82204SH	388
IgA	Patient 1	22	moderate	G82204SH	326
IgA	Patient 1	6	moderate	G82204SH	313
IgG	Patient 1	10	moderate	G82204SH	24
IgG	Patient 1	22	moderate	G82204SH	21
IgM	Patient 1	10	moderate	G82204SH	35
IgM	Patient 1	22	moderate	G82204SH	36
IgA	Patient 2	15	mild	G82204SH	400
IgA	Patient 2	24	mild	G82204SH	457
IgG	Patient 2	15	mild	G82204SH	62